BioSpace News Archive

Business

University of California San Diego and Deerfield Management Create Poseidon Innovation to Advance Disease-Curing Therapeutics

In its first public university partnership, Deerfield commits $65 million to accelerate UC San Diego drug development cycle

September 5, 2018
·
3 min read
Policy

NH-ISAC Changes Name to Health ISAC (H-ISAC)

National Health Information Sharing and Analysis Center (NH-ISAC) to Health Information Sharing and Analysis Center (H-ISAC) Sept. 4, 2018

September 5, 2018
·
2 min read
Deals

Clinical Innovations acquires French company MVF Disposables

Deal strengthens global growth strategy, European presence

September 5, 2018
·
3 min read
Pharm Country

Knopp Biosciences Announces Year 3 Renewal of NIH Blueprint Grant Award for Advancing KCNQ2 Activators in Rare Neonatal Epilepsy

Knopp Biosciences LLC today announced the renewal of its grant award for Year 3 from the National Institutes of Health Blueprint Neurotherapeutics Network (BPN) to advance novel treatments for epilepsy.

September 5, 2018
·
4 min read
Drug Development

Dicerna Announces Proof of Concept for DCR-PHXC in the Treatment of Primary Hyperoxaluria

Initial 6-Week Data in PHYOX Phase 1 Trial Show Significant and Sustained Reduction in Urinary Oxalate Levels Following Single-Dose Administration in Adults with PH1 and PH2

September 5, 2018
·
11 min read
Pharm Country

Many Americans Would Prioritize Finances if Faced with an Advanced Stage Illness According to a New Survey

Fifth Season Financial sheds light on available solutions to financial toxicity

September 5, 2018
·
3 min read
Alkermes Announces 3rd Annual Competitive Grants Program to Support Those Affected by Mental Health and Substance Use Disorders

ALKERMES Inspiration Grants® Program Will Award Up to $1 Million for the Development or Expansion of Innovative Programs

September 5, 2018
·
5 min read
Pharm Country

Headaches Associated With Commuting, Dating And Even Adulting? Now, There’s An Excedrin® For That

Excedrin® Launches Limited Editions Targeting Today’s Top Headache-Inducing Moments

September 5, 2018
·
4 min read
Correvio Reports Preliminary Data Collected from Brinavess Treatment Episodes in EU Post-Authorization Safety Study

Zero Deaths Reported, Safety Outcomes of Interest Observed in 0.8% Cases

September 5, 2018
·
9 min read
Business

Checkmate Pharmaceuticals Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate Combination Therapy with CMP-001 and Avelumab

Phase Ib/II trial will evaluate safety, pharmacokinetics, pharmacodynamics, efficacy of the immunotherapy combination in PD-1/PD-L1-Refractory Advanced Squamous Cell Cancer of the Head and Neck

September 5, 2018
·
6 min read